| |
|
|
|
Entera Bio Ltd.  
|
|
2.8 0.23 (0.09%) |
08-19 15:58 |
|
Open: |
2.5 |
Pre close: |
2.57 |
Target:
|
4.40
|
|
High: |
2.8 |
Low: |
2.3 |
Resistance:
|
3.77
4.40
|
|
Volume: |
24,857 |
Market Cap: |
32M |
Support:
|
2.27
1.35
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.50
 |
MACD |
MACD(12,26):
|
-0.24 |
|
MA(20): |
2.97  |
Signal(12,26,9): |
-0.22 |
|
MA(100): |
3.63 |
Stochastic Oscillator |
%K(14,3):
|
56.54 |
|
MA(250): |
4.25 |
%D(3): |
48.18 |
|
Average Volume(K) |
3-Month: |
1457
|
52-Week |
High:
|
6.40 |
|
10-Days: |
1153 |
Low: |
1.35 |
|
RSI |
RSI(14):
|
46.72 |
Change(%): |
-43.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.957 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
11.46 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
0.0 |
Shares Float (M) |
0.49 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
46.55 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
14.27 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.044 |
Shares Short (K) |
1 |
|
Book Value (p.s.) |
0.670 |
EBITDA (p.s.) |
-0.847 |
P/E |
-2.93 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.18 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.26 |
P/S |
641759936.00 |
|
Operating Margin |
-1959.20 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
-3.47 |
|
|
|
|
|
|
